Breaking News Instant updates and real-time market news.

A

Agilent

$67.14

1.19 (1.80%)

, CREE

Cree

$49.96

-0.32 (-0.64%)

13:07
08/14/18
08/14
13:07
08/14/18
13:07

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include Agilent Technologies (A), consensus 63c... Cree (CREE), consensus 8c... Viavi Solutions (VIAV), consensus 11c.

A

Agilent

$67.14

1.19 (1.80%)

CREE

Cree

$49.96

-0.32 (-0.64%)

VIAV

Viavi

$11.09

0.13 (1.19%)

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 19

    Aug

  • 20

    Aug

  • 05

    Sep

  • 06

    Sep

  • 12

    Sep

A Agilent
$67.14

1.19 (1.80%)

05/15/18
JEFF
05/15/18
NO CHANGE
Target $80
JEFF
Buy
Agilent pullback a buying opportunity, says Jefferies
Jefferies analyst Brandon Couillard recommends using the post-earnings pullback in shares of Agilent Technologies as a buying opportunity. Guidance was maintained, despite dilution from Lasergen, and does not yet capture accretion from the pending AATI deal, Couillard tells investors in a research note. He sees no reason to alter his positive thesis and keeps a Buy rating on Agilent with a slightly reduced price target of $80.
05/15/18
COWN
05/15/18
UPGRADE
COWN
Outperform
Agilent upgraded to Outperform from Market Perform at Cowen
06/08/18
BARD
06/08/18
NO CHANGE
Target $77
BARD
Outperform
Agilent recent weakness a buying opportunity, says Baird
Baird analyst Catherine Ramsey Schulte attended Agilent's analyst day and said her positive outlook on the company remains unchanged. She continues to expect strong core growth and margin expansion to help drive above market performance over the next several years. Schulte said she would use recent weakness as a buying opportunity and reiterated her Outperform rating and $77 price target on Agilent shares.
06/28/18
JPMS
06/28/18
DOWNGRADE
Target $105
JPMS
Underweight
JPMorgan downgrades Varian to Underweight following period of restriction
JPMorgan analyst Tycho Peterson downgraded Varian Medical Systems (VAR) to Underweight from Neutral following a period of restriction. Persistent order growth volatility, a "sluggish" end market and in the near-term and risk from the U.S.-China trade war weigh on the analyst's longer-term outlook for the stock. Varian has a dominant franchise but a mature industry and premium valuation are hard to overlook, Peterson tells investors in a research note. The analyst sees better risk/rewards in other parts of his coverage universe, including tool names Agilent (A), Danaher (DHR) and Thermo Fisher (TMO).
CREE Cree
$49.96

-0.32 (-0.64%)

07/18/18
NOMU
07/18/18
INITIATION
Target $44
NOMU
Neutral
Cree initiated with a Neutral at Nomura Instinet
Nomura initiated Cree with a Neutral and $44 price target.
07/19/18
07/19/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Clorox (CLX) initiated with a Sell at UBS. 2. Cree (CREE) initiated with a Neutral at Nomura Instinet. 3. Paycom (PAYC) initiated with a Buy at Needham. 4. Lonestar Resources (LONE) initiated with a Buy at SunTrust. 5. ON Semiconductor (ON) initiated with a Buy at Nomura Instinet. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/18
NOMU
07/19/18
INITIATION
NOMU
Nomura rolls out Analog Semi coverage, names ON top pick
Nomura Instinet analyst Krysten Sciacca last night rolled out coverage on Analog Semiconductors. The analyst expects the group to outperform throughout the remainder of 2018 given its "steadier business models" versus other semi sectors, "strong" free cash flow generation and the "strong" demand coming from the auto and industrial applications. Her top pick is ON Semiconductor (ON), which the analyst initiated with a Buy rating and $30 price target. ON currently trades at a 35% discount to the Analog group, but its multiple should expand as investors come to better appreciate the company's exposure to industrial and auto, Sciacca told investors in a research note. She believes the company's 2020 target model will likely prove conservative. Sciacca also initiated coverage of Microchip (MCHP) with a Buy rating and $110 price target. The stock currently trades at a 22% discount to the comp group, but its "aggressive" de-leveraging, market share gains, and "strong" executional track record warrant the stock returning to its historical five-year average premium of 2%, the analyst contends. She initiated Cree (CREE) with a Hold rating and $44 price target saying the stock is already pricing in tailwinds and assumed coverage of Analog Devices (ADI) with a Neutral rating and $100 price target.
08/03/18
ADAM
08/03/18
INITIATION
Target $61
ADAM
Buy
Cree initiated with a Buy at Canaccord
Canaccord analyst Jed Dorsheimer initiated Cree with a Buy rating citing the management team's focus on the high power, high value silicon carbide and gallium nitride components and LED components. He believes the company is well positioned in the various secular themes of electrification in the transportation markets as well as high voltage applications in industrial automation. Dorsheimer has a $61 price target on Cree shares.
VIAV Viavi
$11.09

0.13 (1.19%)

07/19/18
JPMS
07/19/18
NO CHANGE
Target $80
JPMS
Neutral
JPMorgan raises 3D Sensing estimates for Lumentum, Viavi
JPMorgan analyst Samik Chatterjee raised his 3D Sensing estimates for both Neutral-rated Lumentum (LITE) and Underweight-rated Viavi (VIAV) to reflect higher market share than previously modeled for both on the upcoming launches of the Apple (AAPL) iPhone and accelerated adoption of 3D Sensing across Apple's portfolio of devices. JPMorgan's technology team's channel checks on Apple's 3D Sensing supply chain have indicated limited new suppliers for the 3D Sensing module, making it more likely that the leaders on the iPhoneX hold onto strong market share positions for longer than previously anticipated, Chatterjee tells investors in a research note. Further, the analyst now believes there is greater visibility into the adoption of 3D Sensing on all three iPhone models and two iPad Pro models to be launched by Apple in the second half of 2018. Chatterjee upped his price target for Lumentum to $80 from $78 and for Viavi to $11 from $10.
08/13/18
NEED
08/13/18
UPGRADE
NEED
Buy
Viavi upgraded to Buy from Hold at Needham
08/13/18
NEED
08/13/18
UPGRADE
Target $13.5
NEED
Buy
Viavi upgraded to Buy at Needham on 'more constructive' outlook
As reported earlier, Needham analyst Alex Henderson upgraded Viavi to Buy from Hold with a price target of $13.50, saying the company's latest update suggests it is working through its restructuring and realignment issues. The analyst notes that the company's 3D sensing business is poised to ramp while its valuation is less priced in than those of its competitors. Henderson also states the the accretion from Viavi's Cobham acquisition announced in February will kick in just as that business approaches a $38.5M FirstNet sole sourcing deal.
08/13/18
08/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Papa John's (PZZA) upgraded to Buy from Neutral at Longbow. 2. Mylan (MYL) and Endo (ENDP) were upgraded to Outperform from Sector Perform at RBC Capital. 3. Dollar Tree (DLTR) upgraded to Overweight from Neutral at Atlantic Equities. 4. Fluor (FLR) upgraded to Buy from Neutral at UBS with analyst Steven Fisher saying he expects Fluor's backlog to inflect positively in Q3 and rise 35%-40% by the middle of 2019. 5. Viavi (VIAV) upgraded to Buy from Hold at Needham with analyst Alex Henderson saying the company's latest update suggests it is working through its restructuring and realignment issues. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ORCL

Oracle

$45.72

-0.9 (-1.93%)

05:32
12/18/18
12/18
05:32
12/18/18
05:32
Recommendations
Oracle analyst commentary  »

Oracle Q2 results a step…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDAQ

Nasdaq

$85.19

-1.3 (-1.50%)

05:30
12/18/18
12/18
05:30
12/18/18
05:30
Hot Stocks
Nasdaq raises offer for proposed acquisition of Cinnober to SEK 87 per share »

On September 14, Nasdaq…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRH

DiamondRock

$9.58

-0.33 (-3.33%)

05:27
12/18/18
12/18
05:27
12/18/18
05:27
Downgrade
DiamondRock rating change  »

DiamondRock downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YNDX

Yandex

$27.49

-0.52 (-1.86%)

05:27
12/18/18
12/18
05:27
12/18/18
05:27
Hot Stocks
Yandex to acquire property site for new Moscow headquarters »

Yandex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHO

Sunstone Hotel

$14.08

-0.32 (-2.22%)

05:23
12/18/18
12/18
05:23
12/18/18
05:23
Downgrade
Sunstone Hotel rating change  »

Sunstone Hotel downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HST

Host Hotels

$17.31

-0.46 (-2.59%)

05:21
12/18/18
12/18
05:21
12/18/18
05:21
Upgrade
Host Hotels rating change  »

Host Hotels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$64.86

-0.78 (-1.19%)

, S

Sprint

$5.83

-0.14 (-2.35%)

05:18
12/18/18
12/18
05:18
12/18/18
05:18
Hot Stocks
T-Mobile, Sprint receives approval from CFIUS, Team Telecom »

T-Mobile (TMUS) and…

TMUS

T-Mobile

$64.86

-0.78 (-1.19%)

S

Sprint

$5.83

-0.14 (-2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPG

Washington Prime

$5.76

-0.38 (-6.19%)

05:18
12/18/18
12/18
05:18
12/18/18
05:18
Downgrade
Washington Prime rating change  »

Washington Prime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBHS

Fortune Brands

$39.62

-0.76 (-1.88%)

05:16
12/18/18
12/18
05:16
12/18/18
05:16
Downgrade
Fortune Brands rating change  »

Fortune Brands downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

05:15
12/18/18
12/18
05:15
12/18/18
05:15
General news
FX Action: USD-JPY extended losses »

FX Action: USD-JPY…

SNDR

Schneider National

$19.12

-0.015 (-0.08%)

05:11
12/18/18
12/18
05:11
12/18/18
05:11
Downgrade
Schneider National rating change  »

Schneider National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$147.63

-3.18 (-2.11%)

05:11
12/18/18
12/18
05:11
12/18/18
05:11
Upgrade
Norfolk Southern rating change  »

Norfolk Southern upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$95.83

-0.86 (-0.89%)

05:10
12/18/18
12/18
05:10
12/18/18
05:10
Downgrade
Kansas City Southern rating change  »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCOI

Cogent

$45.37

-1.25 (-2.68%)

05:07
12/18/18
12/18
05:07
12/18/18
05:07
Upgrade
Cogent rating change  »

Cogent upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$61.50

-2.81 (-4.37%)

05:05
12/18/18
12/18
05:05
12/18/18
05:05
Upgrade
Prologis rating change  »

Prologis upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLNXF

Cellnex

$0.00

(0.00%)

05:02
12/18/18
12/18
05:02
12/18/18
05:02
Downgrade
Cellnex rating change  »

Cellnex downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NXST

Nexstar

$84.01

-1 (-1.18%)

, TRCO

Tribune Media

$45.33

-0.04 (-0.09%)

05:00
12/18/18
12/18
05:00
12/18/18
05:00
Recommendations
Nexstar, Tribune Media analyst commentary  »

Nexstar price target…

NXST

Nexstar

$84.01

-1 (-1.18%)

TRCO

Tribune Media

$45.33

-0.04 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$13.46

-0.84 (-5.87%)

04:56
12/18/18
12/18
04:56
12/18/18
04:56
Initiation
Tailored Brands initiated  »

Tailored Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASOMY

Asos

$0.00

(0.00%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Downgrade
Asos rating change  »

Asos downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIRG

Airgain

$10.70

-0.55 (-4.89%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Airgain management to meet with William Blair »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

CSTM

Constellium

$7.86

0.15 (1.95%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Constellium management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

SMLR

Semler Scientific

$0.00

(0.00%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Semler Scientific management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 07

    Jan

HSII

Heidrick & Struggles

$32.08

-1.43 (-4.27%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Heidrick & Struggles management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ALSN

Allison Transmission

$42.98

-0.33 (-0.76%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Allison Transmission management to meet with Buckingham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

HUN

Huntsman

$18.22

-0.09 (-0.49%)

04:55
12/18/18
12/18
04:55
12/18/18
04:55
Conference/Events
Huntsman management to meet with Seaport Global »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.